Continuation of Antidumping Duty Order: Aspirin From Turkey

[Federal Register Volume 64, Number 161 (Friday, August 20, 1999)]
[Notices]
[Page 45508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21714]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration
[A-489-602]


Continuation of Antidumping Duty Order: Aspirin From Turkey

AGENCY: Import Administration, International Trade Administration, 
Department of Commerce.

ACTION: Notice of Continuation of Antidumping Duty Order: Aspirin from 
Turkey.

-----------------------------------------------------------------------

SUMMARY: On July 6, 1999, the Department of Commerce (``the 
Department''), pursuant to sections 751(c) and 752 of the Tariff Act 
from 1930, as amended (``the Act''), determined that revocation of the 
antidumping duty order on aspirin from Turkey would be likely to lead 
to continuation or recurrence of dumping (64 FR 36328 (July 6, 1999)). 
On August 4, 1999, the International Trade Commission (``the 
Commission''), pursuant to section 751(c) of the Act, determined that 
revocation of the antidumping duty order on aspirin from Turkey would 
likely to lead to continuation or recurrence of material injury to an 
industry in the United States within a reasonably foreseeable time (64 
FR 42414 (August 4, 1999)). Therefore, pursuant to 19 CFR 
351.218(f)(4), the Department is publishing notice of the continuation 
of the antidumping duty order on aspirin from Turkey.

FOR FURTHER INFORMATION CONTACT: Scott E. Smith or Melissa G. Skinner, 
Office of Policy for Import Administration, International Trade 
Administration, U.S. Department of Commerce, 14th and Constitution 
Ave., NW, Washington, DC 20230; telephone (202) 482-6397 or (202) 482-
1560, respectively.

EFFECTIVE DATE: August 20, 1999.

Background

    On March 1, 1999, the Department initiated, and the Commission 
instituted, a sunset review (64 FR 9970 and 64 FR 10012, respectively) 
of the antidumping duty order on aspirin from Turkey pursuant to 
section 751(c) of the Act. As a result of this review, the Department 
found that revocation of the antidumping duty order would likely lead 
to continuation or recurrence of dumping and notified the Commission of 
the magnitude of the margin likely to prevail were the order to be 
revoked. (See Final Results of Expedited Sunset Review: Aspirin from 
Turkey, 64 FR 36328 (July 6, 1999)).
    On August 4, 1999, the Commission determined, pursuant to section 
751(c) of the Act, that revocation of the antidumping duty order on 
aspirin from Turkey would likely lead to continuation or recurrence of 
material injury to an industry in the United States within a reasonably 
foreseeable time. (See Aspirin from Turkey, 64 FR 42414 (August 4, 
1999), and USITC Pub. 3215, Inv. No. 731-TA-364 (Review) (July 1999)).

Scope

    The merchandise covered by this antidumping duty order is 
acetylsalicylic acid (aspirin) from Turkey containing no additives, 
other than inactive substances (such as starch, lactose, cellulose, or 
coloring materials), and/or active substances in concentrations less 
than that specified for particular nonprescription drug combinations of 
aspirin and active substances as published in the Handbook of 
Nonprescription Drugs, eighth edition, American Pharmaceutical 
Association, and is not in tablet, capsule or similar forms for direct 
human consumption. This product is classified under the Harmonized 
Tariff Schedule (HTS) subheading 2918.22.10. The HTS number is provided 
for convenience and customs purposes. The written description remains 
dispositive.

Determination

    As a result of the determinations by the Department and the 
Commission that revocation of this antidumping duty order would be 
likely to lead to continuation or recurrence of dumping and material 
injury to an industry in the United States, pursuant to section 
751(d)(2) of the Act, the Department hereby orders the continuation of 
the antidumping duty order on aspirin from Turkey. The Department will 
instruct the U.S. Customs Service to continue to collect antidumping 
duty deposits at the rate in effect at the time of entry for all 
imports of subject merchandise. Pursuant to section 751(c)(6)(A)(iii) 
of the Act, any subsequent five-year review of this order will be 
initiated not later than the fifth anniversary of the effective date of 
continuation of this order.
    The effective date of continuation of a finding, order, or 
suspension agreement will be the date of publication in the Federal 
Register of the Notice of Continuation. As provided in 19 CFR 
351.218(f)(4), the Department will issue its determination to continue 
a finding, order, or suspended investigation not later than seven days 
after the date of publication in the Federal Register of the 
Commission's determination concluding the sunset review and immediately 
thereafter will publish its notice of continuation in the Federal 
Register. As a result, pursuant to section 751(c)(2) and 751(c)(6)(A) 
of the Act, the Department intends to initiate the next five-year 
review of this order not later than thirty (30) days before the fifth 
anniversary of the effective date of this notice.

    Dated: August 13, 1999.
Robert S. LaRussa,
Assistant Secretary for Import Administration.
[FR Doc. 99-21714 Filed 8-19-99; 8:45 am]
BILLING CODE 3510-DS-P